Loomis, Sayles & Company
RYTM icon

Loomis, Sayles & Company’s Rhythm Pharmaceuticals RYTM Stock Holding History

Loomis, Sayles & Company’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2025
Q2 		$37.4M Sell
591,454
-14,310
-2% -$904K 0.05% 144
2025
Q1 		$32.1M Sell
605,764
-12,721
-2% -$674K 0.05% 159
2024
Q4 		$34.6M Sell
618,485
-18,143
-3% -$1.02M 0.04% 168
2024
Q3 		$33.4M Buy
+636,628
New +$33.4M 0.04% 181